Kliniske studier for Fedme i Oregon
18 studier for Fedme søker deltakere på steder i Oregon.
Byer i Oregon
Offisiell studietekst (engelsk)
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Portland
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07776509A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Summit Headlands, Portland
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07282600A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- AURORA-1 Clinical Site, Eugene
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 16. sep. 2026 · NCT07743463A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Eugene
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 16. sep. 2026 · NCT07743450A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Headlands Reseach- Summit, Portland
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT07351045A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Portland
RekruttererFase 3Frivillige helsepersonell ønskes velkommen
Alder 18 til 79 · Alle kjønn · Oppdatert 11. sep. 2026 · NCT07654374Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
- Corvallis Clinic PC Clinical Research Department, Corvallis
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT07770841A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- Oregon Dermatology and Research Center, Portland
RekruttererFase 4
Alder 18 og eldre · Alle kjønn · Oppdatert 4. sep. 2026 · NCT06857942A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Research Site, Portland
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. aug. 2026 · NCT07784725Brown Adipose Tissue Activation by Spinal Cord Stimulation
- Oregon Health & Science University, Portland
Rekrutterer
Alder 21 til 70 · Alle kjønn · Oppdatert 25. aug. 2026 · NCT04326192Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
- Oregon Health & Science University, Portland
RekruttererFase 2
Alder 7 til 25 · Alle kjønn · Oppdatert 19. aug. 2026 · NCT05082519A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Oregon Health & Science University, Portland
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 18. aug. 2026 · NCT07567001AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
- Northwest Research Center, Portland
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT07509307Testing Just-in-Time Adaptive Interventions (JITAIs) to Prevent Goal Disengagement in Response to Weight Regain
- Oregon Research Institute Community and Evaluation Services, Springfield
Rekrutterer
Alder 18 til 70 · Alle kjønn · Oppdatert 11. aug. 2026 · NCT07708064Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
- ACCOMPLISH-1 Research Site, Portland
RekruttererFase 3
Alder 18 til 79 · Alle kjønn · Oppdatert 10. aug. 2026 · NCT07654361A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
- Velocity Clinical Research, Medford, Medford
RekruttererFase 2
Alder 18 til 80 · Alle kjønn · Oppdatert 22. jul. 2026 · NCT07477704Repeated Far Infrared Sauna Bathing in Adults With Obesity
- University of Oregon, Eugene
Rekrutterer
Alder 18 til 59 · Alle kjønn · Oppdatert 4. mar. 2026 · NCT07158047Sleep and Metabolism
- Oregon Health & Science University, Portland
RekruttererFrivillige helsepersonell ønskes velkommen
Alder 18 til 40 · Alle kjønn · Oppdatert 3. apr. 2024 · NCT05775627Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.